These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4069550)

  • 21. Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
    Díaz-Rubio E; González-Larriba JL; Rosell R; Abad A; Martín M; Valerdi JJ; Barriga JJ
    Ann Oncol; 1990 Sep; 1(5):379-80. PubMed ID: 2261379
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
    Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P
    Oncology; 1992; 49(6):479-83. PubMed ID: 1465288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
    Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
    Donovitz GS; O'Quinn AG; Smith ML
    Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research on antiemetics: an Italian model of success].
    Roila F
    Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.
    Hansen O; Pfeiffer P; Madsen B; Andersen I; Hansen B; Mathiesen B
    Acta Oncol; 1996; 35(1):57-61. PubMed ID: 8619941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
    Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.
    Salles G; Archimbaud E; Thomas X; Fiere D
    Cancer Chemother Pharmacol; 1991; 28(1):77-9. PubMed ID: 2040038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiemetic combination for cisplatin-induced emesis. Results from a controlled study.
    Martín Jiménez M; Diaz-Rubio E
    Bull Cancer; 1986; 73(3):294-8. PubMed ID: 3756365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
    Lee CW; Suh CW; Lee JS; Lee KH; Cho GY; Kim SW; Kim SH
    J Korean Med Sci; 1994 Oct; 9(5):369-75. PubMed ID: 7702784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
    Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Canaletti R; Morsia D; Passalacqua R; DiCostanzo F; Donati D; Colombo N; Ballatori E
    Cancer Treat Rep; 1985 Dec; 69(12):1353-7. PubMed ID: 3907824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB; McDermed JE; Liponi DF
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.
    Grunberg SM; McDermed JE; Bernstein L; Cohen JL
    Cancer Chemother Pharmacol; 1987; 20(4):332-6. PubMed ID: 3690807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL
    Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.
    Onsrud M; Moxnes A; Sollien A; Grande T; Solesvik O
    Cancer; 1988 Jun; 61(12):2429-32. PubMed ID: 3365665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study.
    Giaccone G; Bertetto O; Secat MA; Calciati A
    Oncology; 1988; 45(2):74-8. PubMed ID: 3353076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.